Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GAO local/national coverage decisions report

This article was originally published in The Gray Sheet

Executive Summary

Jan. 31, 2003 targeted as General Accounting Office's submission date to Senate Finance Committee Chairman Max Baucus (D-Mont.), Ranking Member Chuck Grassley (R-Iowa) and Special Committee on Aging Chairman John Breaux (D-La.). The report will analyze local and national coverage trends for new procedures and devices (1"The Gray Sheet" Jan. 21, 2002, In Brief)...

You may also be interested in...



Device coverage policy

General Accounting Office plans to release a report on coverage decisions for new procedures and devices in June, in time to influence congressional debate over Medicare reform legislation, Health Care-Program Administration & Integrity Issues Director Leslie Aronowitz tells HHS secretary's regulatory reform committee in Washington, D.C. Jan. 7. Initiated by GAO, the study will examine the national coverage process, local carrier decisions, and the "hundreds and hundreds of [CPT and HCPCS] codes that get assimilated into the payment system without any formal [coverage] process. We need to understand the extent to which this happens and the rationale that underlies the different pathways," she says...

WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency

The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.

Irish Body Sets Out Five-Year Vision Strategy For Off-Patent Sector

With a focus on drug accessibility, supply chain resilience, and a balanced approach to sustainability, Medicines for Ireland “calls to action” with its five-year plan.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017488

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel